» Articles » PMID: 25888625

A Suppressive Role of Ionizing Radiation-responsive MiR-29c in the Development of Liver Carcinoma Via Targeting WIP1

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Apr 19
PMID 25888625
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide, and it has been linked to radiation exposure. As a well-defined oncogene, wild-type p53-induced phosphatase 1 (WIP1) plays an inhibitory role in several tumor suppressor pathways, including p53. WIP1 is amplified and overexpressed in many malignancies, including HCC. However, the underlying mechanisms remain largely unknown. Here, we show that low-dose ionizing radiation (IR) induces miR-29c expression in female mouse liver, while inhibiting its expression in HepG2, a human hepatocellular carcinoma cell line which is used as a model system in this study. miR-29c expression is downregulated in human hepatocellular carcinoma cells, which is inversely correlated with WIP1 expression. miR-29c attenuates luciferase activity of a reporter harboring the 3'UTR binding motif of WIP1 mRNA. Ectopic expression of miR-29c significantly represses cell proliferation and induces apoptosis and G1 arrest in HepG2. In contrast, the knockdown of miR-29c greatly enhances HepG2 cell proliferation and suppresses apoptosis. The biological effects of miR-29c may be mediated by its target WIP1 which regulates p53 activity via dephosphorylation at Ser-15. Finally, fluorescence in situ hybridization (FISH) and immunohistochemical analyses indicate that miR-29c is downregulated in 50.6% of liver carcinoma tissues examined, whereas WIP1 is upregulated in 45.4% of these tissues. The expression of miR-29c inversely correlates with that of WIP1 in HCC. Our results suggest that the IR-responsive miR-29c may function as a tumor suppressor that plays a crucial role in the development of liver carcinoma via targeting WIP1, therefore possibly representing a target molecule for therapeutic intervention for this disease.

Citing Articles

A miR-34a-guided, tRNA-derived, piR_019752-like fragment (tRiMetF31) suppresses migration and angiogenesis of breast cancer cells via targeting PFKFB3.

Wang B, Li D, Ilnytskyy Y, Kovalchuk I, Kovalchuk O Cell Death Discov. 2022; 8(1):355.

PMID: 35961977 PMC: 9374763. DOI: 10.1038/s41420-022-01054-w.


MiR-29c inhibits HCV replication activation of type I IFN response by targeting STAT3 in JFH-1-infected Huh7 cells.

Wang Y, Li Y RSC Adv. 2022; 8(15):8164-8172.

PMID: 35542013 PMC: 9078521. DOI: 10.1039/c7ra12815k.


Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma.

Chen M, Wang W, Hu S, Tong Y, Li Y, Wei Q Cell Commun Signal. 2022; 20(1):39.

PMID: 35346236 PMC: 8962187. DOI: 10.1186/s12964-022-00850-2.


Identification of potential core genes in gastric cancer using bioinformatics analysis.

Shao C, Wang R, Kong D, Gao Q, Xu C J Gastrointest Oncol. 2021; 12(5):2109-2122.

PMID: 34790378 PMC: 8576244. DOI: 10.21037/jgo-21-628.


The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer.

Jiang A, Liu N, Bai S, Wang J, Gao H, Zheng X Front Genet. 2021; 11:605767.

PMID: 33391354 PMC: 7775311. DOI: 10.3389/fgene.2020.605767.


References
1.
Lu X, Ma O, Nguyen T, Jones S, Oren M, Donehower L . The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell. 2007; 12(4):342-54. DOI: 10.1016/j.ccr.2007.08.033. View

2.
Roy S, Kaur M, Agarwal C, Tecklenburg M, Sclafani R, Agarwal R . p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther. 2007; 6(10):2696-707. DOI: 10.1158/1535-7163.MCT-07-0104. View

3.
Chang T, Yu D, Lee Y, Wentzel E, Arking D, West K . Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2007; 40(1):43-50. PMC: 2628762. DOI: 10.1038/ng.2007.30. View

4.
Castellino R, De Bortoli M, Lu X, Moon S, Nguyen T, Shepard M . Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J Neurooncol. 2007; 86(3):245-56. PMC: 2174521. DOI: 10.1007/s11060-007-9470-8. View

5.
Sengupta S, den Boon J, Chen I, Newton M, Stanhope S, Cheng Y . MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008; 105(15):5874-8. PMC: 2311339. DOI: 10.1073/pnas.0801130105. View